Cellectis S.A. (EPA:ALCLS)
France flag France · Delayed Price · Currency is EUR
1.254
-0.036 (-2.79%)
Oct 2, 2026, 5:35 PM CET

Cellectis Revenue

Cellectis had revenue of $6.90M USD in the quarter ending June 30, 2026, a decrease of -62.05%. This brings the company's revenue in the last twelve months to $63.82M, up 0.61% year-over-year. In the year 2025, Cellectis had annual revenue of $79.59M with 61.72% growth.

Revenue (ttm)
$63.82M
Revenue Growth
+0.61%
P/S Ratio
1.63
Revenue / Employee
$278.70K
Employees
229
Market Cap
91.16M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202579.59M30.38M61.72%
Dec 31, 202449.22M40.02M435.37%
Dec 31, 20239.19M-16.53M-64.26%
Dec 31, 202225.72M-12.87M-33.35%
Dec 31, 202138.60M-20.97M-35.20%
Dec 31, 202059.56M36.57M159.09%
Dec 31, 201922.99M1.56M7.27%
Dec 31, 201821.43M-12.28M-36.43%
Dec 31, 201733.72M-22.73M-40.27%
Dec 31, 201656.45M-4.78M-7.81%
Dec 31, 201561.22M29.22M91.29%
Dec 31, 201432.01M14.51M82.92%
Dec 31, 201317.50M-10.25M-36.93%
Dec 31, 201227.74M7.04M34.00%
Dec 31, 201120.70M-248.54K-1.19%
Dec 31, 201020.95M6.11M41.19%
Dec 31, 200914.84M-2.65M-15.16%
Dec 31, 200817.49M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Nicox16.77M
Fermentalg13.38M
Innate Pharma9.81M
Transgene7.21M
Sensorion6.16M
ABIONYX Pharma4.06M
Adocia2.98M
OSE Immunotherapeutics2.69M
Revenue Rankings